Your browser doesn't support javascript.
loading
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
Eleveld, Thomas F; Schild, Linda; Koster, Jan; Zwijnenburg, Danny A; Alles, Lindy K; Ebus, Marli E; Volckmann, Richard; Tijtgat, Godelieve A; van Sluis, Peter; Versteeg, Rogier; Molenaar, Jan J.
Afiliação
  • Eleveld TF; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands. t.f.eleveld@prinsesmaximacentrum.nl.
  • Schild L; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
  • Koster J; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands.
  • Zwijnenburg DA; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
  • Alles LK; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
  • Ebus ME; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands.
  • Volckmann R; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands.
  • Tijtgat GA; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
  • van Sluis P; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
  • Versteeg R; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
  • Molenaar JJ; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Cancer Res ; 78(21): 6297-6307, 2018 11 01.
Article em En | MEDLINE | ID: mdl-30115695
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Sistema de Sinalização das MAP Quinases / Neuroblastoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Sistema de Sinalização das MAP Quinases / Neuroblastoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda